About MONOVEX
Overview
MONOVEX is a brokerage entity registered in the United Kingdom, with an official domain of monovex.com. The company was founded on June 16, 2025, making it a very recent entrant to the financial services market. Its registered address is 40 Gracechurch Street, London EC3V 0BT, a location in the heart of the City of London financial district.
Despite its London registration, MONOVEX does not appear to hold any regulatory licence from the UK Financial Conduct Authority (FCA) or any other recognised regulatory body. This absence of regulatory oversight is a significant factor for potential clients to consider, as it means the broker is not subject to the standards of client protection, capital adequacy, or dispute resolution that regulated firms must adhere to.
Account Types and Minimum Deposits
MONOVEX offers seven distinct account tiers, each with a high minimum deposit requirement. These range from the BRONZE account, requiring €10,000, to the PREMIUM and VIP accounts, which require €500,000 and €1,000,000 respectively. The DIAMOND, PLATINUM, GOLD, and SILVER accounts sit in between, with minimum deposits of €250,000, €100,000, €50,000, and €25,000.
Notably, maximum leverage information is not provided for any account tier (shown as '--' in the available data). This omission, combined with the very high entry barriers, suggests MONOVEX is targeting high-net-worth individuals or institutional clients rather than retail traders with smaller capital. The account names (VIP, Diamond, etc.) are common in the FX/CFD industry but often signal a marketing focus on exclusivity.
Trading Instruments and Platform
At present, no specific information is available regarding the trading instruments offered by MONOVEX. The known facts list instruments as '--', and there is no mention of a trading platform (such as MetaTrader 4/5, cTrader, or a proprietary platform). This lack of detail makes it impossible to assess what markets—forex, indices, commodities, cryptocurrencies, or others—clients could trade.
Similarly, no information is provided on deposit and withdrawal methods, spreads, commissions, or any additional features like demo accounts, educational resources, or customer support channels. The absence of these fundamental details is a significant gap in the broker's public profile.
Regulatory and Risk Considerations
The most critical point for any prospective client is MONOVEX's unregulated status. As of its founding date, it holds no licence from any known financial authority. In the UK, firms offering financial services are generally required to be authorised by the FCA, especially if they handle client money or offer leveraged products. The absence of such authorisation raises serious questions about the safety of client funds and the broker's compliance with anti-money laundering and client asset segregation rules.
Furthermore, the FXCanary Scam Risk Score assigned to MONOVEX is 75 out of 100, categorised as 'Severe'. This score reflects the combination of very high minimum deposits, lack of regulatory oversight, and the overall opacity of the broker's operations. Traders are strongly advised to exercise extreme caution and conduct thorough due diligence before considering any engagement with MONOVEX.
Target Audience
Based on the account structure, MONOVEX appears to target a very specific, high-net-worth clientele. The minimum deposit of €10,000 for the entry-level BRONZE account is far above what most retail forex brokers require (often $100–$500). The highest tiers demand deposits equivalent to a significant investment portfolio. This positioning suggests MONOVEX may be aiming at accredited investors, family offices, or institutional clients who are accustomed to high-touch, bespoke services.
However, without regulatory oversight or a track record, even wealthy individuals should approach such an offering with caution. The lack of independent reviews or third-party verification further compounds the risks. For retail traders with smaller capital, MONOVEX is clearly not an accessible option.
Conclusion
MONOVEX is a newly established broker registered in the UK but lacking regulatory authorisation. Its account tiers cater exclusively to high-net-worth individuals, with minimum deposits starting at €10,000 and going up to €1,000,000. No details are available about trading instruments, platforms, or operational policies.
The combination of an unregulated status, very high entry barriers, and a severe risk score makes MONOVEX a highly speculative and potentially dangerous choice for any trader. Independent public information is extremely limited, and the broker's own website (monovex.com) would need to be scrutinised closely if it becomes operational. For now, the known facts paint a picture of a high-risk entity that should be avoided pending further verification.
Overview compiled by FXCanary from regulatory records and public data. full MONOVEX review